Amniotics AB (OSTO:AMNI) Short-Term Capital Lease Obligation : kr0.00 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Short-Term Capital Lease Obligation?

Amniotics AB's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Amniotics AB's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (kr0.73 Mil) to Dec. 2022 (kr15.07 Mil) but then declined from Dec. 2022 (kr15.07 Mil) to Dec. 2023 (kr0.00 Mil).

Amniotics AB Short-Term Capital Lease Obligation Historical Data

The historical data trend for Amniotics AB's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Short-Term Capital Lease Obligation Chart

Amniotics AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.85

0.73

15.07

Amniotics AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										-	15.07	-	-	-

Amniotics AB Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Amniotics AB Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Amniotics AB's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.